XFOR Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own XFOR shares is 126, representing 67.66% of the company's common stock.

JPMORGAN CHASE & CO, in the last quarter, reduced its stake in XFOR by -35.94% restricting it's holding to 51.13 thousand shares of worth nearly $71.07K. GROUP ONE TRADING, L.P. also lessened -69.98% of the XFOR shares from its portfolio, reducing its holding to 21.25 thousand shares of worth $29.53K. SG AMERICAS SECURITIES, LLC also shunned XFOR shares holding by -56.32% last quarter which brought its holding to 20.82 thousand shares worth $29.00K.

As per its latest 13F filing, WELLS FARGO & COMPANY/MN increased its stake in XFOR by 16.96% in the last quarter. The institutional holder raised its holding to 40.96 thousand shares having worth more than $56.94K. PALE FIRE CAPITAL SE also added 100% more shares of XFOR to its portfolio, raising its holding to 38.07 thousand shares of worth $52.91K. RESOURCES INVESTMENT ADVISORS, LLC. also increased its XFOR shares holding by 10.36% which brought its holding to 28.47 thousand shares worth $39.58K.

The insider with the most stakes in XFOR is SVLSF V, LLC , 10 percent owner at the company. Additionally, XFOR stock is highly held by President and CEO Ragan Paula and 10 percent owner NeoMed Innovation V L.P. among others.

Company executives, directors, and other insiders own 1.15% percent of X4 Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 8 transaction(s) in which XFOR insiders have sold stock, totaling 692.26K shares. Insiders that have sold shares include RAGAN PAULA, DIBIASE MARY, and MOSTAFA ADAM S..

There have been 0 transaction(s) during the past 6-months in which X4 Pharmaceuticals, Inc. insiders have bought stock, totalling 0 shares

Around 4.26M X4 Pharmaceuticals, Inc. shares are held by insiders, which represents about 1.15% of XFOR stock.

XFOR 10 percent owner, SVLSF V, LLC holds the largest portfolio of the company's shares. XFOR shares owned by SVLSF total nearly 1.85 million.

NEW YORK STATE COMMON RETIREMENT FUND is the largest institutional owner in XFOR which holds 51.55 thousand shares worth $72.00K or 0.03% of the total XFOR shares outstanding followed by JPMORGAN CHASE & CO with ownership of 51.13 thousand shares representing 0.03% of the XFOR ownership. ALLIANCEBERNSTEIN L.P. is the third largest stakeholder with 45.68 thousand shares or 0.03% of the ownership worth more than $63.50K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the XFOR is concerned, it is a stock which is optionable.

Number of XFOR shares short is 11.42M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 170.55M shares of XFOR are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, XFOR has 127.83M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for XFOR is 8.64.